Comment on: No hearing loss associated with the use of artemether-lumefantrine to treat experimental human malaria

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 101, Issue 3, 2007, Pages 314-315

  Toovey, Stephen ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ DERIVATIVE;

AUDIOMETRY; DISEASE PREDISPOSITION; DRUG EXPOSURE; DRUG SAFETY; ETHNICITY; EVOKED BRAIN STEM AUDITORY RESPONSE; HEARING LOSS; HEREDITY; HUMAN; LETTER; MALARIA; NEUROTOXICITY; NONHUMAN; OTOTOXICITY; OXIDATIVE STRESS; PATHOGENESIS; PLASMODIUM FALCIPARUM; STATISTICAL SIGNIFICANCE;

ANTIMALARIALS; ARTEMISININS; DRUG COMBINATIONS; ETHANOLAMINES; FLUORENES; HEARING LOSS; HUMANS; MALARIA, FALCIPARUM; RESEARCH DESIGN;

EID: 33845923818     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trstmh.2006.09.001     Document Type: Letter

References (6)

1. Chinnery P.F., Elliott C., Green G.R., Rees A., Coulthard A., Turnbull D.M., and Griffiths T.D. The spectrum of hearing loss due to mitochondrial DNA defects. Brain 123 (2000) 82-92
2. McCall, M.B., Beynon, A.J., Mylanus, E.A.M., van Sauerwein, R.W., 2006. No hearing loss associated with the use of artemether-lumefantrine to treat experimental human malaria. Trans. R. Soc. Trop. Med. Hyg. 100, 1098-1104.
3. Schmuck G., Roehrdanz E., Haynes R.K., and Kahl R. Neurotoxic mode of action of artemisinin. Antimicrob. Agents Chemother. 46 (2002) 821-827
4. Toovey S. A case-control auditory evaluation of patients treated with artemether-lumefantrine. Am. J. Trop. Med. Hyg. 74 (2006) 939-940
5. Toovey S. Are currently deployed artemisinins neurotoxic?. Toxicol. Lett. 166 (2006) 95-104
6. Toovey S., and Jamieson A. Audiometric changes associated with the treatment of uncomplicated falciparum malaria with co-artemether. Trans. R. Soc. Trop. Med. Hyg. 98 (2004) 261-267